Savior LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Savior LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,500
+22.0%
3,5000.0%0.07%
+108.6%
Q2 2023$8,610
+8.8%
3,5000.0%0.04%
+400.0%
Q1 2023$7,910
-35.2%
3,5000.0%0.01%
-36.4%
Q4 2022$12,215
-90.6%
3,5000.0%0.01%
-90.9%
Q3 2022$130,000
+97.0%
3,5000.0%0.12%
+98.4%
Q2 2022$66,000
-27.5%
3,5000.0%0.06%
-10.3%
Q1 2022$91,000
+19.7%
3,5000.0%0.07%
+2166.7%
Q4 2021$76,000
-17.4%
3,5000.0%0.00%
-96.8%
Q3 2021$92,000
-17.9%
3,5000.0%0.09%0.0%
Q2 2021$112,000
-8.9%
3,5000.0%0.09%
-24.2%
Q1 2021$123,0003,5000.12%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders